Results 191 to 200 of about 17,288 (263)

A rare case of Langerhans cell histiocytosis with unexplained endocrine dysfunction and extensive skeletal involvement in a Pediatric patient. [PDF]

Oxf Med Case Reports
Díaz Q C, Orellana M, Chajon R, Valenzuela J, Chajon P.   +4 more
europepmc   +1 more source

Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry): Protocol for an Open-Label Prospective Randomized Trial.

JMIR Res Protoc
Svendsen AM, Hagstrøm S, Kamperis K, Andersen AE, Henneberg NC, Van Batavia J, Olesen AE, Borch L.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis

Journal of Pediatric Urology, 2021
Enuresis is identified as voluntary or involuntary leakage of urine for at least three consecutive months in the daytime and/or nighttime on clothes for children older than five. Monosymptomatic nocturnal enuresis (MNE) describes nighttime wetting without daytime leakage of urine in children with no pathology in the urinary system and it is 80% more ...
Ali Gözüküçük, Mehmet Kılıç, Basri Çakıroğlu   +2 more
openaire   +4 more sources

Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta‐analysis of randomized controlled trials

Journal of Thrombosis and Haemostasis, 2017
Mjr Desborough, Mjr Desborough, KA Oakland, KA Oakland, G. Landoni, M. Crivellari, C. Dorée, L. Estcourt, L. Estcourt, S. Stanworth, S. Stanworth   +10 more
exaly   +2 more sources

Desmopressin and Hypotension

Annals of Internal Medicine, 1985
Excerpt To the editor: In the review on desmopressin in the August issue (1), the scarcity of side effects is justly emphasized.
Frans H.M. Derkx, E. J. P. Brommer, P. Van Brummelen   +2 more
openaire   +2 more sources

Desmopressin and super platelets

Blood, 2014
In this issue of Blood , Colucci et al provide experimental data supporting the hypothesis that desmopressin (DDAVP) favors the hemostatic process not only by inducing the release of von Willebrand factor (VWF) from endothelial cells, but also by enhancing the procoagulant activity of platelets.[1][
PECCI, ALESSANDRO, BALDUINI, CARLO
openaire   +5 more sources

Pharmacokinetics of Desmopressin [PDF]

, 1993
In 1967 Zaoral and coworkers synthesized several analogues of vasopressin. One of these derivatives, 1-deamino-8-D-arginine vasopressin (DDAVP, desmopressin), soon became the treatment of choice for diabetes insipidus centralis. DDAVP has a prolonged half-life and a decreased pressor activity when compared with the parent hormone vasopressin (VP). This
M. Köhler, Harris Alan
openaire   +1 more source

Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In Vivo

Thrombosis and Haemostasis, 2020
Osteoprotegerin (OPG) regulates bone metabolism by reducing the activation of osteoclasts, but may also be involved in blood vessel calcification and atherosclerosis. Within endothelial cells OPG is stored in Weibel–Palade bodies (WPBs).
Nina Buchtele, Katarina D Kovacevic, C. Brostjan, M. Schwameis, H. Hayden, U. Derhaschnig, C. Firbas, B. Jilma, C. Schoergenhofer   +8 more
semanticscholar   +1 more source